Vimarsana
Biggest News Aggregation in the World

Caplin Point Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Caplin Point Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Caplin Point Labs Today - Breaking & Trending Today

Top 10 Stocks To Buy For Today (31-05-24); Infosys, IRB Infra, Jio Financial, Havells India, KFin Tech, Sun Pharma, Krishna Institute - Vimarsana News

Top 10 Stocks To Buy For Today (31-05-24); Infosys, IRB Infra, Jio Financial, Havells India, KFin Tech, Sun Pharma, Krishna Institute

Sun Pharma Stock: The company to acquire a 14.3% stake in the Indian Foundation for Quality Management for Rs 12.5 crore.

Source: india.com
Nifty jumps over 150 points to hit all-time high, Sensex trades near record peak - Vimarsana News

Nifty jumps over 150 points to hit all-time high, Sensex trades near record peak

Nifty jumped 162.05 points to hit its lifetime high of Rs 21,603.40. The 30-share BSE Sensex pack surged 535.01 points to trade at 71,871.81. At this level, the benchmark is just 41.26 points away from its all-time high of 71,913.07, a level seen earlier this month on December 20.

Sensex rises over 250 points, Nifty tops 21,510; Nerolac Paints & Nuvoco Vistas jump up to 6% - Vimarsana News

Sensex rises over 250 points, Nifty tops 21,510; Nerolac Paints & Nuvoco Vistas jump up to 6%

The 30-share BSE Sensex pack was up 287 points or 0.40 per cent to trade at 71,624, while the broader NSE Nifty moved 88 points or 0.41 per cent up to trade at 21,529.

Stock market holiday: BSE, NSE to remain closed today on account of Christmas - Vimarsana News

Stock market holiday: BSE, NSE to remain closed today on account of Christmas

Stock market holiday: On Friday, the 30-share BSE Sensex pack rose 242 points or 0.34 per cent to settle at 71,107, while the broader NSE Nifty index moved 94 points or 0.44 per cent up to close at 21,349.

caplin point labs shares: Fundamental Radar: Why is Caplin Point Labs poised to see a 20% upside? - Vimarsana News

caplin point labs shares: Fundamental Radar: Why is Caplin Point Labs poised to see a 20% upside?

For Caplin Point, both the US and emerging markets of Latin America and Africa continued to grow, and with a healthy order book and drug approvals, the company hopes to clock revenue growth of 50% for the US markets, which constitute 15% of the total revenue.